NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Medibio Limited (F: BPN)
BPN Technical Analysis
5
As on 15th Dec 2021 BPN SHARE Price closed @ 1.29 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.11 & Strong Buy for SHORT-TERM with Stoploss of 0.01 we also expect STOCK to react on Following IMPORTANT LEVELS. |
BPNSHARE Price
Open | 1.32 | Change | Price | % |
High | 1.35 | 1 Day | -0.04 | -3.01 |
Low | 1.11 | 1 Week | -0.17 | -11.64 |
Close | 1.29 | 1 Month | -0.25 | -16.23 |
Volume | 13887 | 1 Year | 1.28 | 12800.00 |
52 Week High 1.60 | 52 Week Low 0.00 |
F Germany Most Active Stocks
IMU | 0.10 | -99.65% |
IMU | 0.10 | -99.65% |
IMU | 0.10 | -99.65% |
IMU | 0.10 | -99.65% |
IMU | 0.10 | -99.65% |
ENB | 47.60 | -0.92% |
TEF | 3.84 | -0.52% |
TEF | 3.84 | -0.52% |
WHL | 5150.00 | -0.44% |
WDI | 0.05 | -37.50% |
F Germany Top Gainers Stocks
F Germany Top Losers Stocks
BPN Daily Charts |
BPN Intraday Charts |
Whats New @ Bazaartrend |
BPN Free Analysis |
|
BPN Important Levels Intraday
RESISTANCE | 1.75 |
RESISTANCE | 1.60 |
RESISTANCE | 1.51 |
RESISTANCE | 1.42 |
SUPPORT | 1.16 |
SUPPORT | 1.07 |
SUPPORT | 0.98 |
SUPPORT | 0.83 |
BPN Forecast May 2025
4th UP Forecast | 1.31 |
3rd UP Forecast | 1.3 |
2nd UP Forecast | 1.3 |
1st UP Forecast | 1.3 |
1st DOWN Forecast | 1.28 |
2nd DOWN Forecast | 1.28 |
3rd DOWN Forecast | 1.28 |
4th DOWN Forecast | 1.27 |
BPN Weekly Forecast
4th UP Forecast | 1.29 |
3rd UP Forecast | 1.29 |
2nd UP Forecast | 1.29 |
1st UP Forecast | 1.29 |
1st DOWN Forecast | 1.29 |
2nd DOWN Forecast | 1.29 |
3rd DOWN Forecast | 1.29 |
4th DOWN Forecast | 1.29 |
BPN Forecast2025
4th UP Forecast | 4.41 |
3rd UP Forecast | 3.41 |
2nd UP Forecast | 2.79 |
1st UP Forecast | 2.17 |
1st DOWN Forecast | 0.41 |
2nd DOWN Forecast | -0.21 |
3rd DOWN Forecast | -0.83 |
4th DOWN Forecast | -1.83 |
Medibio Limited ( F Germany Symbol : BPN )
Sector : N/A And Other Stocks in Same Sector
Sector : N/A And Other Stocks in Same Sector
BPN Other Details
Segment | EQ | |
Market Capital | 8341590.00 | |
Sector | ||
Industry | ||
Offical website | > echo $website ; ?> |
BPN Address
![]() |
BPN Latest News
BPN Business Profile
Medibio Limited, a health technology company, researches, develops, and commercializes mental health technology to assist in the screening, diagnosing, monitoring, and management of depression and other mental health conditions in Australia and the United States. The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. It has a clinical trial agreement with MedBridge Healthcare LLC to support sleep analysis of depressive burden (SADB) trial. The company was formerly known as BioProspect Limited and changed its name to Medibio Limited in November 2014. Medibio Limited was incorporated in 1987 and is headquartered in Melbourne, Australia. Address: 100 Albert Road, Melbourne, VIC, Australia, 3205
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service